← Back to Patent Explorer
US5059166A Expired / Lapsed US ⏱️ 0.0 years remaining

Intra-arterial stent with the capability to inhibit intimal hyperplasia

Assignee: MEDICAL INNOVATIVE TECHNOLOGIES R & D A Ltd PARTNERSHIP OF LP
•
Filing: 1989-12-11
•
Granted: 1991-10-22
•
Expires: 2009-12-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a means of preventing restenosis of an artery at a trauma site due to intimal hyperplasia. That device comprises a thin wire with a radioactive tip that can temporarily be introduced into the artery and left at the trauma site for a limited period of time.

Inventors

  • 👤 Robert E. Fischell
  • 👤 Tim A. Fischell

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 23:39
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/0077; A61F2/86; A61F2/88; A61K; A61K51/00; A61K51/12; A61K51/1282; A61L; A61L31/00; A61L31/14; A61N; A61N5/00; A61N5/10; A61N5/1001; A61N5/1002; A61F2210/00; A61F2210/0095

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 84 words
An intra-arterial stent comprising a generally tubular structure whose external surface is adapted to engage the arterial wall and which is patent throughout its entire interior length, said stent being formed from a radioactive material which is outwardly, radially expandable after percutaneous insertion into an artery, the radioactive material being adapted to be imbedded into the plaque so that the radioactive material preferentially emits radiation that can reduce the proliferation of cells in the arterial wall that are in close proximity to said stent.
Claim 2
Dependent Claim 84 words
An intra-arterial stent comprising a generally tubular structure whose external surface is adapted to engage the arterial wall and which is patent throughout its entire interior length, said stent being formed from a radioactive material which is outwardly, radially expandable after percutaneous insertion into an artery, the radioactive material being adapted to be imbedded into the plaque so that the radioactive material preferentially emits radiation that can reduce the proliferation of cells in the arterial wall that are in close proximity to said stent.
Claim 3
Dependent Claim 16 words
The stent of claim 1 in which the radioactive material emitting the radiation is a radioisotope.
Claim 4
Dependent Claim 23 words
The stent of claim 2 in which said radioisotope is located within the structural material of said generally tubular structure of the stent.
Claim 5
Dependent Claim 19 words
The stent of claim 2 in which said radioisotope is plated onto said generally tubular structure of the stent.
Claim 6
Dependent Claim 12 words
The stent of claim 2 including an outer coating of anti-thrombogenic material.
Claim 7
Dependent Claim 15 words
The stent of claim 2 in which said radioisotope is a beta particle emitting radioisotope.
Claim 8
Dependent Claim 73 words
An intra-arterial stent comprising a generally tubular, thin-walled structure adapted to be expanded radially outward against the wall of an artery in a human body at least part of said stent being formed from a radioisotope material which is radially expandable, and said radioisotope material being adapted to be imbedded into the plaque within the arterial wall and further being adapted to decrease the rate of proliferative cell growth of the intimal cells.
Claim 9
Dependent Claim 73 words
An intra-arterial stent comprising a generally tubular, thin-walled structure adapted to be expanded radially outward against the wall of an artery in a human body at least part of said stent being formed from a radioisotope material which is radially expandable, and said radioisotope material being adapted to be imbedded into the plaque within the arterial wall and further being adapted to decrease the rate of proliferative cell growth of the intimal cells.
Claim 10
Dependent Claim 17 words
The stent of claim 7 in which said radioisotope has a half-life of less than 100 days.
Claim 11
Independent Claim 90 words
A method to decrease intimal hyperplasia caused by the treatment of an arterial stenosis the method comprising: percutaneous insertion of a radioisotope source into an artery by means of a catheter so that it is positioned at the site of the arterial stenosis, said radioisotope source being formed from a plurality of thin, wire-like, interconnected, radially expandable parts in the form of an intra-arterial stent; radially expanding the radioisotope source so that it becomes imbedded in the plaque within the arterial wall; and, removal of the catheter from the artery.
Claim 12
Independent Claim 90 words
A method to decrease intimal hyperplasia caused by the treatment of an arterial stenosis the method comprising: percutaneous insertion of a radioisotope source into an artery by means of a catheter so that it is positioned at the site of the arterial stenosis, said radioisotope source being formed from a plurality of thin, wire-like, interconnected, radially expandable parts in the form of an intra-arterial stent; radially expanding the radioisotope source so that it becomes imbedded in the plaque within the arterial wall; and, removal of the catheter from the artery.
Claim 13
Dependent Claim 28 words
The method of claim 9 further comprising the step of dilating the stenosis by the use of a balloon angioplasty catheter prior to the insertion of the stent.
Claim 14
Dependent Claim 34 words
The method of claim 9 further comprising the step of excising at least some of the atheromatous plaque of the stenosis by means of an atherectomy catheter prior to the insertion of the stent.

References Cited (Backward Citations)

US3324847A Cited
US3811426A Cited
US3927325A Cited
US4496435A Cited
US4584991A Cited
US4768507A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-10-21 1995-04-22 1995-10-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-10-21 1999-04-22 1999-10-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-10-21 2003-04-22 2003-10-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag